Financials
- Market Capitalization 1.55 B
- Employee 159
- Founded 1996
- CEO N/A
- Website www.inva.com
- Headquarter Delaware, United States
- FIGI BBG000CG9XT7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
6.06
Relación precio/flujo de caja
4.12
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2084 | ABSI Absci Corporation - Common Stock | 9.67 USD | -4.82% | -17.84% | +20.42% | +172.39% | 1.66 B USD | ||
| 2125 | STOK Stoke Therapeutics, Inc. - Common Stock | 24.15 USD | -2.38% | -5.59% | -17.80% | -20.48% | 1.56 B USD | ||
| 2136 | QURE uniQure N.V. - Ordinary Shares | 21.84 USD | -3.32% | -5.13% | -50.67% | -64.43% | 1.51 B USD | ||
| 2140 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.30 USD | -1.16% | +4.79% | +5.96% | -52.11% | 1.51 B USD |